Evidence map›Paper›PMID 27356872›Full record

ReviewStem cell research & therapy2016

Human-animal chimeras: ethical issues about farming chimeric animals bearing human organs.

Rodolphe Bourret, Eric Martinez, François Vialla, Chloé Giquel, Aurélie Thonnat-Marin, John De Vos

Abstract readReview
In one paragraph

Review in Stem cell research & therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. The use of transgenic animals for xenotransplantation: An update.Animal models and experimental medicine · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rodolphe BourretCHU Montpellier, Innovation and Research Division, Montpellier, F34000, France.
Eric MartinezCHU Montpellier, Innovation and Research Division, Montpellier, F34000, France.
François ViallaUniversité de Montpellier, UFR de Droit, Montpellier, F34000, France.
Chloé GiquelCHU Montpellier, Innovation and Research Division, Montpellier, F34000, France.
Aurélie Thonnat-MarinCHU Montpellier, Innovation and Research Division, Montpellier, F34000, France.
John De VosINSERM, U1183, Montpellier, F34000, France. john.devos@inserm.fr.ORCID http://orcid.org/0000-0003-1880-4130

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in stem cells and gene engineering have paved the way for the generation of interspecies chimeras, such as animals bearing an organ from another species. The production of a rat pancreas by a mouse has demonstrated the feasibility of this approach. The next step will be the generation of larger chimeric animals, such as pigs bearing human organs. Because of the dramatic organ shortage for transplantation, the medical needs for such a transgressive practice are indisputable. However, there are serious technical barriers and complex ethical issues that must be discussed and solved before producing human organs in animals. The main ethical issues are the risks of consciousness and of human features in the chimeric animal due to a too high contribution of human cells to the brain, in the first case, or for instance to limbs, in the second. Another critical point concerns the production of human gametes by such chimeric animals. These worst-case scenarios are obviously unacceptable and must be strictly monitored by careful risk assessment, and, if necessary, technically prevented. The public must be associated with this ethical debate. Scientists and physicians have a critical role in explaining the medical needs, the advantages and limits of this potential medical procedure, and the ethical boundaries that must not be trespassed. If these prerequisites are met, acceptance of such a new, borderline medical procedure may prevail, as happened before for in-vitro fertilization or preimplantation genetic diagnosis.

Indexed as

Animals, Genetically ModifiedAnimalsCellular ReprogrammingChimeraHumansInduced Pluripotent Stem CellsMiceOrgan TransplantationRatsSwineAnimalsAnimals Containing Human MaterialChimeraHuman organsInduced pluripotent stem cellsInterspecies chimera

Identifiers

PMID27356872
PMCPMC4928294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.